Skip to main content

Published locations for PATH study: Subcutaneous immunoglobulin safe, effective for CIDP maintenance

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. PATH study: Subcutaneous immunoglobulin safe, effective for CIDP maintenance

User login

  • Reset your password
  • /content/path-study-subcutaneous-immunoglobulin-safe-effective-cidp-maintenance
  • /neurology/article/137633/neuromuscular-disorders/path-study-subcutaneous-immunoglobulin-safe
  • /clinicalneurologynews/article/137633/neuromuscular-disorders/path-study-subcutaneous-immunoglobulin